BioSpace News Archive

Pharm Country

Acorda to Present at Stifel 2018 Healthcare Conference

Acorda Therapeutics, Inc. announced that Acorda’s President and CEO will present at the Stifel 2018 Healthcare Conference.

November 8, 2018
·
3 min read
Business

Seres Therapeutics Reports Third Quarter Financial Results and Provides Operational Updates

Kevin Horgan, M.D. an accomplished drug developer and immunology expert, hired as Chief Medical Officer

November 8, 2018
·
12 min read
BioMidwest

First Patient in Hong Kong Treated with Cardiovascular Systems, Inc. Coronary Orbital Atherectomy System

This procedure marks the first international coronary procedure taking place as a result of the company’s distribution agreement with OrbusNeich®.

November 8, 2018
·
6 min read
Drug Development

ArQule to Present Clinical and Preclinical Data for ARQ 751 at the 30th EORTC/AACR/NCI Symposium

Three poster presentations highlighting clinical data from ARQ 751-101 and preclinical data on ARQ 751 in combination with other agents

November 8, 2018
·
6 min read
Business

Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2018 Financial Results

Preliminary Phase 1 Clinical Study Results Presented at the European Society of Medical Oncology (ESMO) 2018 Congress Demonstrate the Potential of DCC-2618 to Provide Improved and Durable Clinical Outcomes in Second- and Third-Line Patients

November 8, 2018
·
12 min read
Lone Star Bio

Castle Biosciences to Present at the 2018 Canaccord Genuity Medical Technologies & Diagnostics Forum

Castle Biosciences, Inc. today announced that Derek Maetzold will present at the Canaccord Genuity Medical Technologies & Diagnostics Forum.

November 8, 2018
·
1 min read
Business

Innovus Pharmaceuticals to Release Its Third Quarter 2018 Financial Results on Wednesday, November 14, 2018

Innovus Pharmaceuticals, Inc., today announced that the Company will release its third quarter financial results on Wednesday, November 14, 2018.

November 8, 2018
·
3 min read
Business

The Medicines Company Reports Third-Quarter 2018 Results

Loss from continuing operations in the third quarter of 2018 was $51.6 million, or $0.70 per share, compared to a loss of $7.2 million, or $0.10 per share, in the third quarter of 2017

November 8, 2018
·
16 min read
Business

American Family Care Honors Veterans with Free Flu Shots

Health Care Leader to Serve Those Who Have Served Our Country

November 8, 2018
·
3 min read
Biotech Bay

Actym Therapeutics Will Present Data at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting

Presentation will focus on a novel tumor-targeting, systemically-delivered STING pathway agonist that demonstrates robust anti-tumor efficacy in multiple murine cancer models

November 8, 2018
·
2 min read